oint JDRF-Helmsley Charitable Trust Sensor Initiative Seeks to Accelerate Technology Innovation to Improve Glucose Control June 7, 2012 JDRF and BD (Becton, Dickinson and Company) (NYSE:BDX) today announced an extension of their existing ...
Premium Brand to Continue Educating Diabetes Community On the Importance of Therapeutic Footwear in Managing Foot Health June 7, 2012 Orthofeet, a leading designer and manufacturer of biomechanically designed footwear, announced the showcasing of ...
What: Harold Hamm Diabetes Center at the University of Oklahoma Press Conference & Major Announcement When: ...
June 6, 2012 Rhythm announced today the initiation of a Phase 2 clinical trial for RM-131 , the company's novel ghrelin agonist, for the treatment of gastroparesis in patients with Type I and Type II diabetes. Ghrelin is a peptide hormone produced ...
June 6, 2012 Entia Biosciences, Inc. (OTCBB: ERGO) (ENTIA) announced today that it has commenced an exploratory study at a nationally recognized teaching/research hospital on the West Coast to evaluate the clinical tolerability and potential ...
June 6, 2012 Reportlinker.com announces that a new market research report is available in its catalogue: Global Diabetes Diagnostics Industry ...
Contact: Michele Parisi for CeQur 1-925-429-1850 [email protected] ...
Alliance to feature research for their investigational novel basal insulin analog and investigational SGLT-2 inhibitor June 5, 2012 Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company (NYSE: LLY) are pleased to announce that less ...
June 5, 2012 Janssen and Johnson & Johnson (NYSE: JNJ) will provide investors and other interested parties an overview presentation of results from five pivotal Phase 3 studies evaluating investigational canagliflozin for the treatment of Type 2 ...
Three Late-Breakers Accepted for Presentation on June 10 at the Scientific Sessions of the American Diabetes Association June 5, 2012 Janssen Research & Development, LLC (Janssen) announced today that data from five Phase 3 clinical studies ...
Regular plain yogurt consumption may aid in lowering diabetes risk ( ) and reducing insulin resistance . Based on limited scientific evidence, the regulatory body said that "at least three servings of yoghurt per week may reduce the risk of ...
Findings from a UK Biobank study highlight the correlation between prenatal tobacco exposure, childhood/adolescent smoking, and elevated Type 2 diabetes risk in adulthood, especially for those with a genetic predisposition, according to preliminary ...
Continuous glucose monitors (CGMs) ( ) represent a cutting-edge class of medical devices utilized in the management of both type 1 and type 2 diabetes . CGMs serve as either a substitute for or a complement to traditional blood glucose ...
Indian scientists have achieved a potential advancement in insulin delivery for diabetes patients by creating a unique silk-based hydrogel system that imitates the pancreas ( ). Innovative System Mirroring Pancreatic Function ...
Health experts declared on World Glaucoma Day that diabetes stands as the primary cause of blindness among individuals of working age. World Glaucoma Day ( ) is observed every year on March 12, to raise awareness about the set of eye diseases that can ...
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers